SMS Pharmaceuticals earnings call announcements

Every SMS Pharmaceuticals earnings call announcement on NSE and BSE, newest first, each with its own page.

Time

3 announcements

1 Aug 2026 17:10 IST NSE

SMS Pharma reported Q1FY27 revenue of ₹207 Cr (+6% YoY) with stable EBITDA margins at ~20%. Strategy focuses on high-value APIs and peptide R&D.

30 May 2026 13:03 IST NSE

SMS Pharma delivered FY26 revenue of ₹887cr (+13%) and PAT of ₹102cr (+47%). Strategy focuses on backward integration and high-margin API expansion.

23 May 2026 18:12 IST BSE

SMS Pharma reported strong FY26 performance with PAT reaching ₹102 crore (up 48% YoY) and EBITDA margins expanding to 19%.